Filing Details
- Accession Number:
- 0001209191-19-020889
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-03-21 21:01:50
- Reporting Period:
- 2019-01-07
- Accepted Time:
- 2019-03-21 21:01:50
- Original Submission Date:
- 2019-01-09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1711675 | Nightstar Therapeutics Plc | NITE | () | 4/A |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1041126 | A David Fellows | C/O Nightstar, Inc. 203 Crescent Street, Suite 303 Waltham MA 02453 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2019-01-07 | 8,733 | $12.98 | 626,395 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
- On January 9, 2019, a Form 4 was filed to report a transaction of the Reporting Person to cover tax liabilities pursuant to the Issuer's mandatory sell-to-cover policy. The report provided by the Issuer's equity administrator contained errors relating to the Reporting Person's holdings which have been corrected herein. This Form 4/A amends and restates, in its entirety, the original Form 4.